Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Davunetide

EU orphan designation number: EU/3/10/728
Active ingredient: Davunetide
Indication: Treatment of progressive supranuclear palsy
Sponsor: FGK Representative Service GmbH
Heimeranstraße 35, 80339 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/03/2010 Orphan designation EMEA/OD/129/09 (2010)2053 of 23/03/2010
19/04/2013 Removal of orphan designation from Community Register